Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 31, 2023

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of NightHawk Biosciences, Inc. (the “Registrant”) hereby certifies, to such officer’s knowledge, that:

 

(1)

the accompanying Annual Report on Form 10-K of the Registrant for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

L.

Date: March 31, 2023

 

 

 

 

 

By:

/s/ William L. Ostrander

 

 

Name: William L. Ostrander

 

 

Title: Chief Financial Officer

 

 

(Principal Financial Officer and Principal Accounting Officer)